Disruption of bone marrow stromal cell function by etoposide

Biology of Blood and Marrow Transplantation

Volumn 3, Issue 3, 1997, Pages 122-132

  Gibson, Laura F ^a   Fortney, James ^a   Landreth, Kenneth S ^a   Piktel, Debra ^a   Ericson, Solveig G ^a   Lynch, Joseph P ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Bone marrow microenvironment; Etoposide; Hematopoietic transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; ETOPOSIDE; FIBRONECTIN; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BIOSYNTHESIS; BONE MARROW CELL; CELL ADHESION; CELL CULTURE; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; ERYTHROID PRECURSOR CELL; HUMAN; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; STROMA CELL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE MARROW CELLS; CELL ADHESION; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; ERYTHROID PROGENITOR CELLS; ETOPOSIDE; FIBRONECTINS; HUMANS; LYMPHOCYTE ACTIVATION; STROMAL CELLS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031203045     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Lum LG: The kinetics of immune reconstitution after human marrow transplantation. Blood 69:369, 1987.
2. Witherspoon R, Lum L, Strob R, Thomas ED: Transplant related immune deficiency in man. In: RP Gale (ed) Recent Advances in Bone Marrow Transplantation. New York: Liss, 473, 1983.
3. Pirsh JD, Maki G: Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Ann Intern Med 104:619, 1986.
4. Kagan, JM, Champlin RE, Saxon A: B-cell dysfunction following human bone marrow transplantation: functional-phenotypic dissociation in the early post-transplant period. Blood 74:777, 1989.
5. Kincade PW, Lee G, Watanabe T, Sun L, Scheid MP: Cells and molecules that regulate B lymphopoiesis in bone marrow. Annu Rev Immunol 7:111, 1989.
6. Dorshkind K: Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 8:111, 1990.
7. Whitlock CA, Witte ON: Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci USA 79:3608, 1982.
8. Wolf ML, Buckley JA, Goldfarb A, Law CL, LeBien TW: Development of a bone marrow culture for maintenance and growth of normal human B cell precursors. J Immunol 147:3324, 1991.
9. Dittel BN, LeBien TW: The growth response to IL-7 during normal human B cell ontogeny is restricted to B-lineage cells expressing CD34. J Immunol 154:58, 1995.
10. McGinnes K, Quesniaux V, Hitzler J, Paige CJ: Human B-lymphopoiesis is supported by bone marrow-derived stromal cells. Exp Hematol 19:294, 1991.
11. Weisdorf D, Katsanis E, Verfaille C, Ramsay NKC, Haake R, Garrison L, Blazar BR: Interleukin-1α administration after autologous transplantation: A phase I/II clinical trial. Blood 84:2044, 1994.
12. Smith PJ, Soues S: Multilevel therapeutic targeting by topoisomerase inhibitors. Br J Cancer Suppl 23:47, 1994.
13. Haskell CM: Antineoplastic agents. In: CM Haskell (ed) Cancer Treatment. Philadelphia, PA: W.B. Saunders, 71, 1995.
14. Herzig RH, Lynch J, Christiansen NP, Fay JW, Davis MP, Stevens DA, Pineiro SL, Herzig GP: Dose intensive chemotherapy with etoposide - cyclophosphamide without stem cell support for advanced breast cancer: preliminary results. Presented at the Autologous Marrow and Blood Transplantation Society's Seventh International Symposium; August 17, 1994; Arlington, TX.
15. Gibson LF, Piktel D, Landreth KS: Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells. Blood 82:3005, 1993.
16. Collins LS, Dorshkind K: A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis. J Immunol 138:1082, 1987
17. Gibson LF, Lynch JP, Fortney J, Ericson S, Landreth KS: Functional disruption of bone marrow stromal cells following exposure to etoposide. In: JS Greenberger, A Keating (eds) The Hematopoietic Microenviromnent. Cambridge: Cambridge University Press. In press.
18. Hahn BK, Piktel D, Gibson LF, Landreth KS: The role of stromal integrin interactions in pro-B cell proliferation. In: JS Greenberger, A Keating (eds) The Hetnatopoietic Microenvironment. Cambridge: Cambridge University Press. In press.
19. Harris SE, Fornsaglio J, Piktel D, Landreth KS, Gibson LF: Stromal cell regulation of apoptosis in pro-B cells. In: JS Greenberger, A Keating (eds) The Hematopoietic Microenviromnent. Cambridge: Cambridge University Press. In press.
20. Gibson LF, Narayanan R, Piktel D, Nunez G, Landreth KS: Stromal cells regulate bcl-2 and bax expression in pro-B cells. Exp Hematol 24:628, 1996.
21. Ryan DH, Nuccie BL, Abboud CN, Winslow JM: Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells. J Clin Invest 88:995, 1991.
22. Miyake K, Medina K, Ishihara K, Kimoto M, Auerbach R, Kincade PW: A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J Cell Biol 114:557, 1991
23. Dittel BN, McCarthy JB, Wayner EA, LeBien TW: Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1). Blood 81:2272, 1993.
24. Miyake K, Weisman IL, Greenberger JS, Kincade PW: Evidence for a role of tbe integrin VLA-4 in lympho-hemopoiesis. J Exp Med 173:599, 1991.
25. Dittel BN, LeBien TW: Reduced expression of vascular cell adhesion molecule-1 on bone marrow stromal cells isolated from marrow transplant recipients correlates with a reduced capacity to support human B lymphopoiesis in vitro. Blood 86:2833, 1995.
26. Cavazzana M, Calvo F, Facchin P, Barreau P, Geny B, Dal Cortivo L, Dresch C: Use of liquid culture and cell cycle analysis to compare drug damage following in vitro treatment of normal human bone marrow cells with adriamycin, arabinosyl-cytosine, and etoposide. Exp Hematol 16:876, 1988.
27. Gringeri A, Keng PC, Borch RF: Diethyldithiocarbamate inhibition of murine bone marrow toxicity caused by cisdiamminedichloroplatinum (II) or diamine-(1,1,-cyclobutanedicarboxylato) platinum (11). Cancer Res 48:5708, 1988.
28. Weitzman SA, Gordon LI: Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 76:655, 1990.
29. Kaldor JM, Day NE, Pettersson F, Clarke A, Pedersen D, Mehnert W, Bell J, Host H, Prior P, Karjalainen S, Neal F, Koch M, Band P, Choi W, Pompe Kirn V, Arslan A, Zaren B, Belch AR, Storm H, Kittelmann B, Fraser P, Stovall M: Leukemia following chemotherapy for ovarian cancer. N Engl J Med 322:1, 1990.
30. Wathen LM, DeGowin RL, Gibson DP, Knapp SA: Residual injury to the hemopoietic microenvironment following sequential radiation and busulfan. Int J Radiat Oncol Biol Phys 8:1315, 1982.
31. Greenberger JS, Newburger PE, Sakakeeny MA: Phorbol myristate acetate stimulates macrophage proliferation and differentiation and alters granulopoiesis and leukemogenesis in long term bone marrow cultures. Blood 56:368, 1980.
32. Cohen GI, Greenberger JS, Canellos GP: Electron microscopic changes occurring in bone marrow stromal cells exposed to cytotoxic drugs in vitro. Symposium on scanning EM of bone marrow. Scanning Electron Microsc 1:359, 1982.
33. Greenberger JS, Epperly MW, Jahroudi N, Pogue-Geile KL, Berry LA, Bray J, Goltry KL: Role of bone marrow stromal cells in irradiation leukemogenesis. Acta Haematol 96:1, 1996.
34. Narparstek E, Pierce J, Metcalf D, Shadduck R, Ible J, Leder A, Sakakeeny MA, Wagner K, Falco J, Fitzgerald TJ, Greenberger JS: Induction of growth alterations in factor-dependent hematopoietic progenitor cell lines by cocultivation with irradiated bone marrow stromal cell lines. Blood 67:1395, 1986.
35. Van Leeuwen FE, Chorus AMJ, van den Belt-Dusebout AW, Hagenbeek A, Noyan R, van Kerkhoff EHM, Pinedo HM, Somers R: Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 12:1063, 1994.
36. Pui CH, Ribeiro RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, Head DR, Behm FG, Mahmoud MH, Sandland JT, Crist WM: Acute myeloid luekemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 325:1682, 1991.